Continuous Manufacturing Centers Of Excellence Measure Resurfaces In US House
Stand-alone bill headed for Senate, where it fared poorly in coronavirus response legislative packages.
You may also be interested in...
House tries again to promote advanced technology for the return of pharmaceutical manufacturing to the US in post-COVID-19 era.
The association for manufacturers of generics and biologics calls for public sector investment in priority medicines.
A fresh executive order from US president Joe Biden calls for short-term and long-term study, broad consultation, and co-ordination with allies on the domestic supply chain.